Weihong Zhong | Microbiology | Research Excellence Award

Published on by Global Academic Awards

Prof. Dr. Weihong Zhong | Microbiology | Research Excellence Award

Zhejiang Univeristy of Technology | China

Prof. Dr. Weihong Zhong is a leading researcher in industrial microbiology, biochemical engineering, and metabolic engineering, with strong emphasis on microbial biodegradation, synthetic and systems biotechnology, and biological transformation of pollutants and high-value compounds. His work integrates omics analysis, metabolic pathway engineering, and microbial consortia design to address challenges in environmental bioremediation, green bioprocessing, and sustainable biotechnology. With 100 Scopus-indexed publications, 1,945 citations, and an h-index of 23, he has made impactful contributions to phthalate ester degradation, nicotine catabolism, engineered yeast biosynthesis, and microbial detoxification mechanisms, demonstrating sustained research excellence and international scholarly influence.

Citation Metrics (Scopus)

2000

1500

1000

500

0

Citations
1,945

Documents
100

h-index
23

■ Citations
■ Documents
■ h-index


View Scopus Profile
      View Orcid Profile

Featured Publications

Renu Chaudhary | Fungal Biology | Best Researcher Award

Published on by Global Academic Awards

Dr. Renu Chaudhary | Fungal Biology | Best Researcher Award

CSIR-Institute of Genomics and Integrative Biology | India

Dr. Renu Chaudhary, Ph.D., is a highly accomplished researcher from Delhi, India, with a decade of experience in microbiology, molecular biology, genomics, and genome editing. She possesses advanced technical expertise in CRISPR/Cas9, qPCR, cloning, NGS library preparation, and bioinformatics tools including BLAST, Cytoscape, and R programming. Her work focuses on fungal pathogens, antimicrobial resistance, and metal homeostasis in dermatophytes, supported by prestigious fellowships from DST and ICMR. As a Project Scientist at CSIR-IGIB, she has contributed significantly to transcriptomic and antifungal resistance studies, producing impactful findings in drug discovery and microbial genomics. With 17 research publications, 108 citations, and an h-index of 6, Dr. Renu Chaudhary’s scholarly impact is evident across reputed journals like Expert Review of Molecular Diagnostics, Future Microbiology, and Current Topics in Medicinal Chemistry. She has received multiple awards including Best Paper and Best Poster honors and maintains active membership in the Indian Science Congress Association, showcasing her dedication to advancing biotechnology and molecular research excellence.

Profile: Scopus | Orcid | Google Scholar

Featured Publications

Chaudhary, R., Singh, B., Kumar, M., Gakhar, S. K., Saini, A. K., & Parmar, V. S. (2015). Role of single nucleotide polymorphisms in pharmacogenomics and their association with human diseases. Drug Metabolism Reviews, 47(3), 281–290. Cited by: 62.

Balhara, M., Chaudhary, R., Ruhil, S., Singh, B., Dahiya, N., & Parmar, V. S. (2016). Siderophores; iron scavengers: the novel & promising targets for pathogen specific antifungal therapy. Expert Opinion on Therapeutic Targets, 20(12), 1477–1489. Cited by: 33.

Ahlawat, S., Chaudhary, R., Dangi, M., Bala, K., Singh, M., & Chhillar, A. K. (2020). Advances in tuberculous meningitis diagnosis. Expert Review of Molecular Diagnostics, 20(12), 1229–1241. Cited by: 18.

Chaudhary, R., Balhara, M., Jangir, D. K., Dangi, M., & Chhillar, A. K. (2019). In silico protein interaction network analysis of virulence proteins associated with invasive aspergillosis for drug discovery. Current Topics in Medicinal Chemistry, 19(2), 146–155. Cited by: 11.

Khatri, S., Kumar, M., Phougat, N., Chaudhary, R., & Chhillar, A. K. (2016). Perspectives on phytochemicals as antibacterial agents: An outstanding contribution to modern therapeutics. Mini Reviews in Medicinal Chemistry, 16(4), 290–308. Cited by: 8.

Thakur, Z., Chaudhary, R., & Mehta, P. K. (2024). Deciphering the role of VapBC toxin-antitoxin systems in Mycobacterium tuberculosis stress adaptation. Future Microbiology, 19(18), 1587–1599. Cited by: 7.

Chaudhary, R., Singh, B., & Chhillar, A. K. (2016). Ethnomedicinal importance of Rauvolfia serpentina L. Benth. Ex Kurz in the prevention and treatment of diseases. Natural Products: Research Reviews, 3, 305–326. Cited by: 4.

Khalid Abd El Ghany | Microbial biotechnology | Best Researcher Award

Published on by Global Academic Awards

Assist Prof Dr. Khalid Abd El Ghany | Microbial biotechnology | Best Researcher Award

Assist Prof Dr. Khalid Abd El Ghany, Egyption Drug Authoriity, Egypt

Dr. Khalid Abd El Ghany is a Post-Approval Control Manager at the Egyptian Drug Authority (since 2021) with over two decades of experience in the pharmaceutical sector. He holds a Ph.D. in Genetic Engineering and Biotechnology from Al-Sadat City University (2018) and has completed post-doctoral research at the Egyptian Drug Authority. He is a skilled researcher with numerous publications and expertise in microbial biotechnology. A recipient of the Egyptian Drug Authority Hero’s Certificate (2022) and the Ideal Pharmacist Award (2016), Dr. Khalid is also active in social initiatives, holding leadership roles in various organizations. 📚🌍

 

Publication profile

Google Scholar

Education Background

Dr. Khalid Abd El Ghany has a distinguished educational background in pharmacy and biotechnology. He earned his B.Sc. in Pharmacy with honors from Al-Azhar University, Egypt, in 1994. Later, he pursued an M.Sc. in Microbial Biotechnology from Al-Sadat City University (2012-2014), further advancing his expertise with a Ph.D. in Genetic Engineering and Biotechnology from the same institution in 2018. Since 2020, he has been a post-doctoral researcher at the Egyptian Drug Authority, where he continues to contribute to the field of microbial biotechnology. 📘🔬

 

Professional Experience

Dr. Khalid Abd El Ghany has extensive experience in pharmaceutical regulation and management. Since 2021, he has served as the Post-Approval Control Manager at the Egyptian Drug Authority (EDA). From 2017 to 2021, he was the Deputy Head of the Inspection Department at NODCAR, where he also worked in the Microbiology Lab from 2012 to 2017. His career began as a pharmacist at Arab Drug Company (1995-1996), followed by years in the private pharmaceutical sector, where he was the owner and director from 1996 to 2011. 🌟🔬

 

Research Focus

Dr. Khalid Abd El Ghany’s research is primarily centered on microbial biotechnology and genetic engineering. His work involves probiotics, especially Lactobacillus acidophilus, in cancer treatment and antioxidant activities. He also focuses on vaccine design, integrating immunoinformatics and cheminformatics to target pathogens like Klebsiella pneumoniae and Pseudomonas aeruginosa. Additionally, Dr. Khalid has contributed to studies on β-glucan production, antimicrobial agents, and the potential of probiotics against viral infections, including COVID-19. His work is diverse, covering biotechnology, immunology, and pharmaceutical sciences. 🧬💉

 

Conclusion

With his strong academic background, significant experience in pharmaceutical regulation, a proven track record in research, and leadership in social initiatives, Assist. Prof. Dr. Khalid Abd El Ghany is a strong candidate for the Best Researcher Award. His dedication to both scientific advancement and community service makes him a well-rounded contender for this recognition.

 

Publication Top Notes

  • A potential role of Lactobacillus acidophilus LA1 and its exopolysaccharides on cancer cells in male albino mice – 43 citations (2015) 📑🧬
  • In Silico Designing of a Multitope Vaccine against Rhizopus microsporus – 26 citations (2021) 💉🖥️
  • Evaluation of antioxidant and antitumor activities of Lactobacillus acidophilus bacteria – 20 citations (2014) 🧪🦠
  • Screening and molecular identification of lactic acid bacteria producing β-glucan – 13 citations (2022) 🧬🍏
  • Description of isolated LAB producing β-glucan and evaluation of its therapeutic effect – 11 citations (2016) 🧫🩺
  • Integration of Immunoinformatics and Cheminformatics for Vaccine Design – 5 citations (2023) 🧬💉
  • Molecular Characterization and Optimization of β-Glucan Production from Pediococcus parvulus – 3 citations (2018) 🧬📊
  • Lactiplantibacillus plantarum and Saussurea costus as Therapeutic Agents – 2 citations (2023) 🧬💊
  • Role of probiotic bacteria against virus pathogenesis: Defence against COVID-19 – 1 citation (2024) 🦠🧬
  • Efficacy of β-glucan in an acute model of diabetes – 1 citation (2022) 🩺📊
  • Synthesis, Molecular Docking Studies of Pyrazolo[1,5-a]pyrimidines – 2023 📑⚗️